Hairna Care

Menthol, Salicylic Acid, Panthenol


Maypharm
Human Otc Drug
NDC 82344-060
Hairna Care also known as Menthol, Salicylic Acid, Panthenol is a human otc drug labeled by 'Maypharm'. National Drug Code (NDC) number for Hairna Care is 82344-060. This drug is available in dosage form of Shampoo. The names of the active, medicinal ingredients in Hairna Care drug includes Menthol - .3 g/100mL Panthenol - .2 g/100mL Salicylic Acid - .25 g/100mL . The currest status of Hairna Care drug is Active.

Drug Information:

Drug NDC: 82344-060
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Hairna Care
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Menthol, Salicylic Acid, Panthenol
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Maypharm
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Shampoo
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:MENTHOL - .3 g/100mL
PANTHENOL - .2 g/100mL
SALICYLIC ACID - .25 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Oct, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 22 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:MAYPHARM
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:2100019
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:L7T10EIP3A
WV9CM0O67Z
O414PZ4LPZ
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
82344-060-021 BOTTLE in 1 CARTON (82344-060-02) / 300 mL in 1 BOTTLE (82344-060-01)01 Oct, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose anti-hair loss

Product Elements:

Hairna care menthol, salicylic acid, panthenol menthol menthol salicylic acid salicylic acid panthenol panthenol water sodium c14-16 olefin sulfonate

Indications and Usage:

Uses ■ helps relieve hair loss symptoms.

Warnings:

Warnings for external use only ■ consult with a specialist if there are abnormal symptoms or side effects such as red spots, swelling, or itching caused by direct sunlight when using cosmetics or after use. ■ refrain from using it in areas with wounds, etc. ■ precautions for storage and handling a. keep out of reach of children. b. keep away from direct sunlight. ■ wash immediately when it gets in your eyes ■ if not washed after use, it may cause hair loss or discoloration, so be careful.

Dosage and Administration:

Directions ■ while the hair is wet, take an appropriate amount, massage it lightly, and then wash it.

Package Label Principal Display Panel:

Package label.principal display panel image of carton

Further Questions:

Questions ■ 82 2 6933 6086 ■ maypharm@maypharm.co.kr


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.